Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • PBR vs GSK✓SelectedUSD · GSKPBR vs GSK performance historyLatest closeAs of-5.67%11/16
Stock and ETF performance explorer

PBR vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+1,339.2%
GSK return
+193.2%
Excess return
+1,146.0%
Maximum drawdown
-95.3%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for all.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-5.7%-0.1%-5.6%-5.6%
7D-5.7%-1.3%-4.4%-5.0%
30D-33.5%+2.7%-36.2%-34.8%
3M-0.4%+2.7%-3.1%-3.1%
6M-10.0%+3.3%-13.3%-13.4%
YTD+52.3%+6.5%+45.9%+41.0%
1Y+36.9%+10.7%+26.3%+23.6%
3Y+56.7%+64.4%-7.7%+3.7%
5Y+425.5%+46.7%+378.8%+259.3%
10Y+520.6%+109.4%+411.2%+233.2%
All+1,339.2%+193.2%+1,146.0%+503.6%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over all: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

all analysis · Full analysis span regression · 6 months rolling